Novartis says study shows Gilenya benefits patients with MS
ZURICH (Reuters) - Novartis said studies show its Gilenya drug helped keep patients with multiple sclerosis free of the disease.
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/9HM4XiTntKI/story01.htm
No comments:
Post a Comment